Seattle Genetics

Seattle Genetics

Seattle Genetics

Biotechnology company focused on innovative monoclonal antibody-based therapies for the treatment of cancer. View our Twitter guidelines our site
Type
B2b
Founded
1998
Raised
$9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$9,000,000
Post-IPO equity - 2014
Takeda Pharmaceutical
Team Size
1–10
Employees
Xconomy

Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals

Xconomy

Seattle Genetics Gets Early FDA Nod for Breast Cancer Combo Drug

GeekWire

Seattle Genetics gets FDA approval for breast cancer treatment drug Tukysa

MedCity News

Daiichi Sankyo sues Seattle Genetics over antibody-drug conjugate technology

GeekWire

Seattle Genetics shares rise on strong Adcetris sales, $218M in revenue for Q2

GeekWire

Seattle Genetics shares slump after losses grow

GeekWire

Seattle Genetics drug rides FDA fast-track to the front lines in fight against rare form of cancer

ChinaMoneyNetwork , Reuters Top News , ZDNet , +3

Baidu's COO Lu Qi Steps Down Less Than Two Years After Joining The Firm

Strategy Asia
GeekWire

Seattle Genetics finds mixed success in first earnings after Cascadian Therapeutics acquisition

Earnings Health
MedCity News

Seattle Genetics lands fifth Adcetris approval as investors shrug

GeekWire

Seattle Genetics to acquire Cascadian Therapeutics for $614M to further bolster its cancer fight

Health
Xconomy

Bio Buyout Spree Continues as SeaGen Bets $614M on Cascadian Cancer Drug

Health Strategy
GeekWire

Seattle Genetics COO taking the reigns at stealthy biotech startup Silverback Therapeutics

Strategy Funding
GeekWire

Seattle Genetics beats earnings expectations as lead drug Adcetris finds market success

Earnings Health
GeekWire , Xconomy

Seattle Genetics cancer drug clinical trials will go forward after FDA lifts hold

Health
Xconomy

Seattle Genetics Puts Up $250M for Immunomedics Cancer Drug Rights

Health
GeekWire

Shares of Seattle Genetics tumble after FDA places clinical hold on leukemia drug following patient deaths

GeekWire

Seattle Genetics announces successful clinical trial of lymphoma treatment

Health Science
The Motley Fool

Seattle Genetics Has Been Heating Up: Time to Buy?

The Motley Fool

Taking Inventory on Seattle Genetics, Inc. Earnings

Earnings Health Stock markets